Portfolio

Portfolio News

March 9, 2026

The Hotel Communication Network takes pride of place at the Meyer Jabara Hotels Annual Executive Conference in Rhode Island

March 9, 2026

To The Market gets a feature in the first edition of Impact Insights Magazine

March 9, 2026

Sinaptica Therapeutics takes home the MedTech World Pitch Competition prize - hear about the win from CEO Ken Mariash

January 23, 2026

Dosen announces the release of their latest feature: Charlie, a market-first employee development CoPilot. Find out more and get a free demo of Charlie and Dosen

January 23, 2026

UHubs co-founder Ash Ali joins Revenue Innovations founder Richard Ellis on a podcast unpacking How to Turn Your Sales Kick Off Into a Revenue & Performance Multiplier

January 23, 2026

From stranger to Customer Success Lead in 10 days, Limelight are breaking records and making moves with a big commercial hire to kick off the year

After walking away with a $1M win from SaaStock 2025, Limelight have been invited to deliver a keynote speech on stage at SaaStock Austin 2026

October 31, 2025

Sinaptica Therapeutics lights up the Times Square Tower after ranking top 4% in the MedTech Innovator 2025 Accelerator Cohort.

October 31, 2025

Limelight wins €1,000,000 in investment after coming 1st place at SaaStock start-up competition

October 31, 2025
July 29, 2025

Reeplayer livestreaming is now free and accessible wherever you are in the world. Read the post here to see a win that really matters!

July 29, 2025

Sinaptica has won a second patent by the USPTO, granting protection for its novel Gen2 dual-stimulation modality, combining electrical and magnetic stimulation.

This patent covers the method of enhancing memory by concurrently stimulating any functional brain network related to memory using a synergistic combination of tACS + TMS.

Based on its remarkable ability to boost long-term associative memory in healthy normals by 60-80% (see Phase 1 POC study), our Gen2 device is currently being tested in a multicenter Phase 2 study in early-stage Alzheimer's (interim readout est. Q1-26).  

If successful, triples system capacity-- designed as a faster, seamless plug-and-play upgrade to our Gen1 installed base with the potential for further improving upon the efficacy achieved in our Phase 2 studies. 

This is an exciting new addition to Sinaptica's growing IP portfolio and part of a broader vision to cover the entire spectrum from performance enhancement, memory preservation, and dementia prevention to treating Alzheimer’s.  

The team intends to further expand the scope of this new patent grant beyond memory enhancement into neurodegenerative disease and other related areas through pursuing additional continuation filings.

Latest one-pager and pitch deck 

July 7, 2025

Sinaptica Therapeutics announced a seminal MOA paper published in the peer-reviewed journal Alzheimer’s & Dementia: The Journal of the Alzheimer's Association®representing a major milestone in laying the scientific foundation for precision network-targeted brain stimulation for the treatment of Alzheimer's.

July 7, 2025

Reeplayer and Native Frame drop a 31-page deep dive into youth & amateur sports, live streaming, access gaps, tech trends, and what actually matters to teams; CEO Orhan Basak Ajredinovski and team piloted a Reeplayer-powered live commentary feature during the U.S. Pro Cup at the Beach Soccer Championships in Oceanside.

July 7, 2025

Emilie Svirin, founder of personal safety app MiSeia is set to take the stage at the upcoming Women's Safety Panel Event hosted by Women in Tech.

July 7, 2025

Hotel Communication Network CEO Kevin Bidner and team secure the successful acquisition of Crave Interactive, a UK-based innovator specialising in digital guest experiences for luxury hotels.

July 7, 2025

Uhubs named the UK’s “One to Watch” in Tech Nation Rising Stars competition, taking home a prize of a whopping £1m investment, and were also recently featured as TechRound’s Startup of the Week.

Very well done to co-founders Matt Milligan and Ash Ali.

crossmenu